
==== Front
Sao Paulo Med J
Sao Paulo Med J
Sao Paulo Med J
São Paulo Medical Journal
1516-3180
1806-9460
Associação Paulista de Medicina - APM

15448814
10.1590/S1516-31802004000300012
Original Article
Central retinal vein prethrombosis as an initial manifestation of protein S deficiency
Pré-trombose da veia central da retina como manifestação inicial da deficiência de proteína SPierre Paulo de Tarso Ponte Filho *
Pierre Alessandra Maria Mont'Alverne *
Nascimento Maurício Abujamra *
Marcondes Ana Maria *
Address for correspondence: Paulo de Tarso Ponte Pierre-Filho. R. Alexandre Fleming, s/n. Departamento de Oftalmologia, Faculdade de Ciências Médicas Universidade Estadual de Campinas (Unicamp) Campinas /SP — Brasil — CEP 13081-970. Tel./Fax (+55 19) 3788-7936 E-mail: paulopierre@hotmail.com
Conflict of interest: None

06 5 2004
2004
122 3 134135
23 10 2003
29 12 2003
05 2 2004
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons license.
ABSTRACT

CONTEXT:

Retinal vein thrombosis is most common in old people, and is often associated with systemic vascular disease. One of its rare systemic causes is protein S deficiency.

CASE REPORT:

A case of a 21-year-old woman with retinal vein prethrombosis associated only with protein S deficiency is described. She presented with acutely reduced visual acuity and a central scotoma in her left eye. Warfarin therapy was initiated, and complete improvement in ophthalmoscopic findings was subsequently observed. This case illustrates that protein S deficiency is a factor that should be considered in cases of retinal vein occlusion, particularly in young patients.

RESUMO

CONTEXTO:

Trombose venosa retiniana é mais comum em pessoas idosas e freqüentemente está associada com doença vascular sistêmica. Uma causa sistêmica rara é a deficiência de proteína S.

RELATO DE CASO:

Um caso de paciente branca, de 21 anos, com pré-trombose de veia central da retina associada à deficiência isolada de proteína S é descrito. Ela apresentou súbito embaçamento visual e escotoma central em olho esquerdo. Terapia cumarínica foi iniciada e completa remissão dos achados oftalmoscópicos foi observada. Este caso mostra que deficiência de proteína S deve ser um fator que deve ser considerado em casos de oclusão venosa retiniana, particularmente em pacientes jovens.

KEY WORDS:

Retinal vein
Protein S deficiency
Vascular diseases
Case reports
PALAVRAS-CHAVE:

Veia retiniana
Deficiência de proteína S
Doenças vasculares
Relatos de casos
==== Body
pmcINTRODUCTION

Central retinal vein thrombosis is typically a disease of older patients, rarely occurring in young adults. It is often associated with either an underlying vascular disease or a procoagulant state.1 Hypertension, diabetes, vasculitides, and dyslipidemia are the most commonly associated vascular disorders, while the recognized procoagulant states include thrombocytosis, polycythemia, macroglobulinemia, the use of oral contraceptive pill or systemic lupus erythematosus.

Protein S and protein C are vitamin K-dependent plasma proteins that modulate coagulation. Protein S serves as a cofactor for protein C to inhibit the clotting cascade at the levels of factors V and VIII.2 There are few reports of retinal vein thrombosis associated with protein S deficiency,3,4 and these have usually occurred in combination with other thrombophilic conditions. This case report describes a young patient with protein S deficiency who developed central retinal vein prethrombosis. No other prothrombotic risk factors were present.

CASE REPORT

A 21-year-old white woman presented with acutely reduced visual acuity and a central scotoma in her left eye. She did not present photophobia, ocular pain, fever or any other local or systemic complaint. The patient had no personal or family history of eye disease, systemic hypertension, diabetes mellitus, thrombophilia, malignancy or use of oral contraceptive pills. Her best-corrected visual acuity was 20/15 in the right eye and 20/25 in the left. The anterior segment examination was unremarkable, without papillary defects, and the intraocular pressures were 12 mmHg in the right eye and 11 mmHg in the left eye. Ophthalmoscopy of the left eye showed rare dot and blot hemorrhages and blurring of the optic disc. The retinal venules appeared moderately tortuous but undilated. In the right eye, the ophthalmoscopy was normal. Fluorescein angiography of the left eye revealed normal arterial filling but delayed arteriovenous filling, and there was late disc hyperfluorescence compatible with prethrombosis (Figure 1). However, the right eye was normal. The results from hematological tests showed an erythrocyte sedimentation rate of 18 mm/hour, and the complete blood count, prothrombin time, partial thromboplastin time and anticardiolipin antibodies were normal. She was negative for anti-nuclear antibodies, rheumatoid factor, lupus anticoagulant antiphospholipid antibodies, and serum protein electrophoresis. The activated protein C resistance, plasma levels of protein C and antithrombin III were normal. Decreased plasma levels were found for both free protein S (6%; normal is 20-40%), and total protein S (36%; normal is 60-140%).

Figure 1 Bottom: Photograph showing rare dot and blot hemorrhages and blurring of optic disc in the left eye. The optic disc, macula, and retinal vessels appear normal in the right eye. Top: Fluorescein angiogram showing late optic disc hyperfluorescence; the disc is extremely edematous on the left.

Warfarin therapy was initiated. One month later, the visual acuity of the left eye was 20/20 and complete improvement in ophthalmoscopic findings was noted. Neither parents nor siblings were available for ocular and systemic examination.

DISCUSSION

Central retinal vein thrombosis in young adults is considered uncommon and has been difficult to characterize because the cause is often unknown. Although there is no consensus, it seems appropriate to refer patients with central retinal vein occlusion for thrombophilia screening if they are younger than 50 years old.5-7

Prince et al.3 reported a patient with systemic lupus erythematosus and acquired protein S deficiency causing central retinal vein thrombosis. Bertram et al.7 measured protein C, protein S, and antithrombin III concentrations in ocular vascular occlusive disease, and found a pathologically reduced anti-thrombin III level in one patient with branch venous occlusion, and severely altered protein C and protein S concentrations in two patients with central retinal vein occlusion.

Protein S deficiency, a condition that may be either inherited or acquired, may result in a hypercoagulable state and it predisposes affected individuals to thrombotic events. In the inherited form, clinical manifestations usually occur before the age of 30 years. It is transmitted as an autosomal dominant trait. The deficiency can be acquired under conditions like septic shock, disseminated intravascular coagulation, acute respiratory distress syndrome, postoperative states, liver diseases, pregnancy, oral contraceptive pill use, human immunodeficiency virus infection and chemo-therapy for breast cancer.8 The initial presentation of prethrombosis in this patient was related to protein S deficiency.

Recognition of an association of protein S with thrombotic disease may suggest specific therapeutic approaches. In our patient, therapy with oral anticoagulant was initiated because of the known risk of the recurrence of thrombosis in cases of protein S deficiency.8

We suggest that protein S deficiency should be considered in the cases of some patients with unexplained retinal vascular occlusions, particularly when occurring in young patients or when there is a positive family history of thrombotic disease.

Paulo de Tarso Ponte Pierre-Filho, MD. Department of Ophthalmology, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Alessandra Maria Mont'Alverne Pierre, MD. Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil.

Maurício Abujamra Nascimento, MD. Department of Ophthalmology, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Ana Maria Marcondes, MD. Department of Ophthalmology, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Sources of funding: None

Department of Ophthalmology, Universidade Estadual de Campinas (Unicamp), Campinas, São Paulo, Brazil
==== Refs
REFERENCES

1 Kohner EM Cappin JM Do medical conditions have an influence on central retinal vein occlusions? Proc R Soc Med 1974 67 10 1052 1054 4427899
2 Walker FJ Regulation of activated protein C by a new protein. A possible function for bovine protein S J Biol Chem 1980 255 12 5521 5524 6892911
3 Prince HM Thurlow PJ Buchanan RC Ibrahim KM Neeson PJ Acquired protein S deficiency in a patient with systemic lupus erythematosus causing central retinal vein thrombosis J Clin Pathol 1995 48 4 387 389 7615865
4 Raus P Stalmans P Demeuter E Spileers W Dralands L Unusual retinal vasculitis in a patient with protein S deficiency and systemic toxoplasmosis: a case report Bull Soc Belge Ophthalmol 2001 279 7 12
5 Fong AC Schatz H Central retinal vein occlusion in young adults Surv Ophthalmol 1993 37 6 393 417 8516752
6 Tekeli O Gursel E Buyurgan H protein S and antithrombin III deficiencies in retinal vein occlusion Acta Ophthalmol Scand 1999 77 6 628 630 10634552
7 Bertram B Remky A Arend O Wolf S Reim M Protein C, protein S, and antithrombin III in acute ocular occlusive diseases Ger J Ophthalmol 1995 4 6 332 335 8751097
8 Greaves M Aging and the pathogenesis of retinal vein thrombosis Br J Ophthalmol 1997 81 10 810 811 9486015
